VISIONAERIES Trademark

Trademark Overview

On Friday, October 13, 2017, a trademark application was filed for VISIONAERIES with the United States Patent and Trademark Office. The USPTO has given the VISIONAERIES trademark a serial number of 87644834. The federal status of this trademark filing is REGISTERED as of Tuesday, March 12, 2019. This trademark is owned by Aerie Pharmaceuticals, Inc.. The VISIONAERIES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Provider of research and development services for others in the fields of ophthalmology, medicinal chemistry, cell biology, and pharmacology; conducting research and clinical trials for others relating to pharmaceuticals in the fields of ophthalmology, medicinal chemistry, cell biology, and pharmacology
visionaeries

General Information

Serial Number87644834
Word MarkVISIONAERIES
Filing DateFriday, October 13, 2017
Status700 - REGISTERED
Status DateTuesday, March 12, 2019
Registration Number5698470
Registration DateTuesday, March 12, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 28, 2018

Trademark Statements

Goods and ServicesProvider of research and development services for others in the fields of ophthalmology, medicinal chemistry, cell biology, and pharmacology; conducting research and clinical trials for others relating to pharmaceuticals in the fields of ophthalmology, medicinal chemistry, cell biology, and pharmacology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 23, 2017
Primary Code042
First Use Anywhere DateTuesday, January 16, 2018
First Use In Commerce DateTuesday, January 16, 2018

Trademark Owner History

Party NameALCON INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFribourg CH-1701
CH
Party NameAerie Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameAerie Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameAerie Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBedminster, CA 07921

Trademark Events

Event DateEvent Description
Tuesday, March 12, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 1, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 22, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 12, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, February 5, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, February 4, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 29, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 29, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 14, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 13, 2018USE AMENDMENT FILED
Monday, January 14, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 13, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, October 23, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 28, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 28, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 8, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 20, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 19, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 16, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 16, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 13, 2018ASSIGNED TO LIE
Saturday, June 30, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 2, 2018UNDELIVERABLE MAIL - COURTESY COPY MAILED
Wednesday, January 31, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 31, 2018NON-FINAL ACTION E-MAILED
Wednesday, January 31, 2018NON-FINAL ACTION WRITTEN
Tuesday, January 23, 2018ASSIGNED TO EXAMINER
Monday, October 23, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 17, 2017NEW APPLICATION ENTERED

Related Keywords

visionaeries medicinal cell biology pharmacology ophthalmology chemistry fields research others trials